Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 7Terminated 4Unknown 3Not yet recruiting 3Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Gastrointestinal 4Thoracic 3Sarcoma 3Head & Neck 3Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2Lymphoid 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 79Carboplatin 66pembrolizumab 61Bevacizumab 56Cisplatin 48Specimen Handling 29Drug Therapy 26Blood Specimen Collection 24Cyclophosphamide 20olaparib 19Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14fludarabine 14Brachytherapy 14Radiotherapy 13abemaciclib 12Topotecan 11Nivolumab 11Injections 11Doxorubicin 11lenvatinib 10Fluorouracil 10atezolizumab 9Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Indocyanine Green × Gynecologic × Clear all
NCT06840418 2025-02-21

Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis

Obstetrics & Gynecology Hospital of Fudan University

Phase NA Recruiting
15 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04845828 2022-02-21

SELYE

Asan Medical Center

Phase NA Recruiting
810 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡